Basic Information
RNALocate ID: RLID:11004252
RNA Symbol: hsa-miR-320b
Localization: Exosome
RNA Information
RNA Name: hsa-miR-320b
RNA ID: miRBase:MIMAT0005792
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 27278097
Tissue/Cell Line: Pooled sera
Method: miRNA array
Condition: Acute rejection (AR)|Bronchiolitis obliterans syndrome (BOS)|Stable
Description: Exosomes were defined by flow cytometry for CD63 and western blotting for annexin V SAgs, collagen V (Col-V) and Kα1 tubulin were examined by electron microscopy; miRNAs were profiled by a miRNA array. The global miRNA analysis demonstrated 123 detectable miRNAs (i.e., at least 1 pool with positive detection signal) in sera exosomes. Of these, 15 miRNAs were higher and 108 miRNAs were lower in AR LTxRs compared to stable LTxRs (Table S1). In contrast, 44 miRNAs were higher and 79 miRNAs were lower in BOS LTxRs compared to stable LTxRs (Table S1).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002752 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01002753 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002754 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002755 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002756 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002757 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11004253 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11004254 Exosome Ovarian follicular fluid 22116803
RLID:11004255 Exosome Plasma 23663360
RLID:11004256 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11004257 Microvesicle Plasma 23077538
RLID:11004258 Microvesicle Seminal plasma 23539611
RLID:11004259 Microvesicle Hepatoma cells 23771658
RLID:11004260 Microvesicle Serum 24797360
RLID-D:11000750 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
RLID-D:11001649 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-320b Multiple sclerosis chronic progressive MNDR-E-MI-39356
MNDR hsa-miR-320b Oral squamous cell carcinoma MNDR-E-MI-39357
MNDR hsa-miR-320b High-grade serous ovarian carcinoma MNDR-E-MI-39358
MNDR hsa-miR-320b Estrogen-receptor positive breast cancer MNDR-E-MI-39359
MNDR hsa-miR-320b Estrogen-receptor negative breast cancer MNDR-E-MI-39360
MNDR hsa-miR-320b Progesterone-receptor positive breast cancer MNDR-E-MI-39361
MNDR hsa-miR-320b Progesterone-receptor negative breast cancer MNDR-E-MI-39362
MNDR hsa-miR-320b Her2-receptor positive breast cancer MNDR-E-MI-39363
MNDR hsa-miR-320b Prostate cancer MNDR-E-MI-39364
MNDR hsa-miR-320b Gastric cancer MNDR-E-MI-39365
MNDR hsa-miR-320b Alzheimer disease MNDR-E-MI-39366
MNDR hsa-miR-320b Intracranial aneurysm MNDR-E-MI-39367
MNDR hsa-miR-320b Huntington disease MNDR-E-MI-39368
MNDR hsa-miR-320b Chorea MNDR-E-MI-39369
MNDR hsa-miR-320b Cardiovascular disease MNDR-E-MI-39370
MNDR hsa-miR-320b Carotid stenosis MNDR-E-MI-39371
MNDR hsa-miR-320b Moyamoya disease MNDR-E-MI-39372
MNDR hsa-miR-320b Down syndrome MNDR-E-MI-39373
MNDR hsa-miR-320b Parkinson disease MNDR-E-MI-39374
MNDR hsa-miR-320b Breast cancer MNDR-E-MI-39375
MNDR hsa-miR-320b Pancreatic cancer MNDR-E-MI-39376
MNDR hsa-miR-320b Nephroblastoma MNDR-E-MI-39377
MNDR hsa-miR-320b Colon adenocarcinoma MNDR-E-MI-39378
MNDR hsa-miR-320b Multiple sclerosis relapsing-remitting MNDR-E-MI-39379
MNDR hsa-miR-320b Carcinoma ductal breast MNDR-E-MI-39380
MNDR hsa-miR-320b Glioblastoma MNDR-E-MI-39381
MNDR hsa-miR-320b Glioma MNDR-E-MI-39382
MNDR hsa-miR-320b Chronic obstructive pulmonary disease MNDR-E-MI-39383
MNDR hsa-miR-320b Amyotrophic lateral sclerosis MNDR-E-MI-39384
MNDR hsa-miR-320b Osteosarcoma MNDR-E-MI-39385
MNDR hsa-miR-320b Liver cancer MNDR-E-MI-39386
MNDR hsa-miR-320b Gastric adenocarcinoma MNDR-E-MI-39387
MNDR hsa-miR-320b Lung squamous cell carcinoma MNDR-E-MI-39388
MNDR hsa-miR-320b Lung adenocarcinoma MNDR-E-MI-39389
MNDR hsa-miR-320b Adrenocortical cancer MNDR-E-MI-39390
MNDR hsa-miR-320b Thyroid carcinoma MNDR-E-MI-39391
MNDR hsa-miR-320b Ovarian carcinoma MNDR-E-MI-39392
MNDR hsa-miR-320b Myasthenia gravis autoimmune experimental MNDR-E-MI-39393
MNDR hsa-miR-320b Carcinoma renal cell MNDR-E-MI-39394
MNDR hsa-miR-320b Kidney renal papillary cell carcinoma MNDR-E-MI-39395
MNDR hsa-miR-320b Renal clear cell carcinoma MNDR-E-MI-39396
MNDR hsa-miR-320b Cholangiocarcinoma MNDR-E-MI-39397
MNDR hsa-miR-320b Esophageal cancer MNDR-E-MI-39398
MNDR hsa-miR-320b Liver cirrhosis MNDR-E-MI-39399
MNDR hsa-miR-320b Head and neck squamous cell carcinoma MNDR-E-MI-39400
MNDR hsa-miR-320b Heart failure MNDR-E-MI-39401
MNDR hsa-miR-320b Fibromyalgia MNDR-E-MI-39402
MNDR hsa-miR-320b Progressive multifocal leukoencephalopathy MNDR-E-MI-39403
MNDR hsa-miR-320b Breast invasive carcinoma MNDR-E-MI-39404
MNDR hsa-miR-320b Hepatocellular carcinoma MNDR-E-MI-39405
MNDR hsa-miR-320b B-cell lymphoma MNDR-E-MI-39406
MNDR hsa-miR-320b Rheumatoid arthritis MNDR-E-MI-39407
MNDR hsa-miR-320b Neuromyelitis optica MNDR-E-MI-39408
MNDR hsa-miR-320b Skin cutaneous melanoma MNDR-E-MI-39409
MNDR hsa-miR-320b Skin melanoma MNDR-E-MI-39410
MNDR hsa-miR-320b Colorectal cancer MNDR-E-MI-39411
MNDR hsa-miR-320b Nasopharynx carcinoma MNDR-E-MI-39412
MNDR hsa-miR-320b Nasopharyngeal cancer MNDR-E-MI-39413
MNDR hsa-miR-320b Venous thromboembolism MNDR-E-MI-39414
MNDR hsa-miR-320b Chronic pain MNDR-E-MI-39415
MNDR hsa-miR-320b Stroke lacunar MNDR-E-MI-39416
MNDR hsa-miR-320b Breast cancer her3+ negative MNDR-E-MI-39417
MNDR hsa-miR-320b Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-39418
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABHD13 Homo sapiens RR00025353
TOP